3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
1
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
9
Glioblastoma
6
Sarcoma
3
Glioma
3
Brain Neoplasms
3
Pancreatic Neoplasms
2
Neoplasms
2
Astrocytoma
2
Urothelial Carcinoma of the Bladder
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Hyperplasia
1
Pathologic Complete Response
1
Paranasal Sinus Neoplasms
1
Oligodendroglioma
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Muscle-invasive Urothelial Cancer of the Bladder
1
Melanoma
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Giant Cell Tumor of Bone
1
Estrogen Receptor Positive Breast Cancer
1
Ependymoma
1
Craniopharyngioma
1
Carcinoma, Non-Small-Cell Lung
1
Alzheimer Disease
1
Interventions
Surveys and Questionnaires
114
Exercise
103
Blood Specimen Collection
99
Radiotherapy
66
Gemcitabine
64
Bevacizumab
57
Standard of Care
56
Cisplatin
55
Cyclophosphamide
51
Capecitabine
50
Carboplatin
49
Docetaxel
47
pembrolizumab
46
Dexamethasone
46
Paclitaxel
45
Interviews as Topic
43
Oxaliplatin
40
Magnetic Resonance Spectroscopy
39
Fluorouracil
37
Methods
36
Irinotecan
36
Therapeutics
33
Drug Therapy
32
Radiosurgery
31
Nivolumab
30
Erlotinib Hydrochloride
27
Educational Status
26
Everolimus
24
Leucovorin
23
Control Groups
23
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms
×
Transurethral Resection of Bladder
×
Clear all
NCT07067749
2025-07-24
TEMPO-MIBC
University of Rome Tor Vergata
Phase 3
Recruiting
92 enrolled
NCT05684874
2023-10-30
SarQuantIRM
Centre Leon Berard
Phase NA
Unknown
25 enrolled